Experienced healthcare investors know several important facts regarding large-cap, blue-chip biopharma companies. First, these firms enjoy a limited amount of time when their blockbuster drugs corner a specific niche. Then, patent protections expire and generic competitors can join the party. Second, that creates pressure to ensure that pipelines are full with new potential blockbusters. Third, [...] The post Innovation Is Crucial to Healthcare Sector Long-Term Growth appeared first on ETF Trends .